These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 27995280)

  • 1. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
    Alwahsh SM; Gebhardt R
    Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose and liver function--is this behind nonalcoholic liver disease?
    Jin R; Vos MB
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):490-5. PubMed ID: 26203597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.
    Simopoulos AP
    Nutrients; 2013 Jul; 5(8):2901-23. PubMed ID: 23896654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease.
    Hamza RT; Ahmed AY; Rezk DG; Hamed AI
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1345-1352. PubMed ID: 27442361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructose and NAFLD: The Multifaceted Aspects of  Fructose Metabolism.
    Jegatheesan P; De Bandt JP
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
    Ter Horst KW; Serlie MJ
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Softic S; Cohen DE; Kahn CR
    Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
    Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
    Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights.
    Federico A; Rosato V; Masarone M; Torre P; Dallio M; Romeo M; Persico M
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
    Azevedo VZ; Dall'Alba V
    Clin Nutr; 2021 Jun; 40(6):4275-4283. PubMed ID: 33551215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
    Moore JB; Gunn PJ; Fielding BA
    Nutrients; 2014 Dec; 6(12):5679-703. PubMed ID: 25514388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).
    Chen Q; Wang T; Li J; Wang S; Qiu F; Yu H; Zhang Y; Wang T
    Nutrients; 2017 Jan; 9(2):. PubMed ID: 28146130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method to induce nonalcoholic steatohepatitis (NASH) in mice.
    Savari F; Mard SA; Badavi M; Rezaie A; Gharib-Naseri MK
    BMC Gastroenterol; 2019 Jul; 19(1):125. PubMed ID: 31307427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.